Scilex Holding Company Increase (Decrease) in Inventories
Scilex Holding Company (SCLX) reported Increase (Decrease) in Inventories of -$617.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-14
- Scilex Holding Company increase (decrease) in inventories for the quarter ending 2026-06-30 was -$360.00K.
- Scilex Holding Company increase (decrease) in inventories for the quarter ending 2026-03-31 was -$257.00K, a 144.01% decline year-over-year.
- Scilex Holding Company increase (decrease) in inventories for the quarter ending 2025-12-31 was -$509.00K, a 1597.06% decline year-over-year.
- Scilex Holding Company increase (decrease) in inventories for the quarter ending 2025-09-30 was -$1.38M.
- Scilex Holding Company increase (decrease) in inventories for fiscal 2025 was -$1.80M.
- Scilex Holding Company increase (decrease) in inventories for fiscal 2024 was -$1.46M, a 151.52% decline from fiscal 2023.
- Scilex Holding Company increase (decrease) in inventories for fiscal 2023 was $2.84M.
- Scilex Holding Company increase (decrease) in inventories for fiscal 2022 was -$1.18M, a 183.56% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$360.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$617.00K 10-Q · filed 2026-08-14 | -$1.13M derived: sum of 3 quarters · filed 2026-08-14 | -$2.50M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$257.00K 10-Q · filed 2026-05-20 | -$766.00K derived: sum of 2 quarters · filed 2026-05-20 | -$2.14M derived: sum of 3 quarters · filed 2026-05-20 | -$2.64M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | -$1.89M derived: sum of 2 quarters · filed 2026-04-10 | -$2.38M derived: sum of 3 quarters · filed 2026-08-14 | -$1.80M 10-K · filed 2026-04-10 |
| 2025-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$1.87M derived: sum of 2 quarters · filed 2026-08-14 | -$1.29M 10-Q · filed 2025-11-14 | -$1.26M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $88.00K 10-Q · filed 2026-08-14 | $122.00K derived: sum of 3 quarters · filed 2026-08-14 | -$236.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $584.00K 10-Q · filed 2026-05-20 | $618.00K derived: sum of 2 quarters · filed 2026-05-20 | $260.00K derived: sum of 3 quarters · filed 2026-05-20 | -$152.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | -$324.00K derived: sum of 2 quarters · filed 2026-04-10 | -$736.00K derived: sum of 3 quarters · filed 2026-04-10 | -$1.46M 10-K · filed 2026-04-10 |
| 2024-09-30 | -$358.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$770.00K derived: sum of 2 quarters · filed 2025-11-14 | -$1.50M 10-Q · filed 2025-11-14 | -$1.22M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$1.14M 10-Q · filed 2025-08-13 | -$865.00K derived: sum of 3 quarters · filed 2025-08-13 | -$32.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$726.00K 10-Q · filed 2025-05-14 | -$453.00K derived: sum of 2 quarters · filed 2025-05-14 | $380.00K derived: sum of 3 quarters · filed 2025-05-14 | $1.22M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.11M derived: sum of 2 quarters · filed 2025-03-31 | $1.94M derived: sum of 3 quarters · filed 2025-03-31 | $2.84M 10-K · filed 2025-03-31 |
| 2023-09-30 | $833.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-17 | $1.67M derived: sum of 2 quarters · filed 2025-01-17 | $2.56M 10-Q · filed 2025-01-17 | $3.01M derived: sum of 4 quarters · filed 2025-01-17 |
| 2023-06-30 | $835.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.73M 10-Q · filed 2024-08-13 | $2.18M derived: sum of 3 quarters · filed 2024-08-13 | $1.95M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $897.00K 10-Q · filed 2024-05-13 | $1.34M derived: sum of 2 quarters · filed 2024-05-13 | $1.11M derived: sum of 3 quarters · filed 2024-05-13 | $335.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $445.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $218.00K derived: sum of 2 quarters · filed 2024-03-12 | -$562.00K derived: sum of 3 quarters · filed 2024-03-12 | -$1.18M 10-K · filed 2024-03-12 |
| 2022-09-30 | -$227.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.01M derived: sum of 2 quarters · filed 2023-11-14 | -$1.63M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$780.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$1.40M 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | -$622.00K 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $1.42M 10-K · filed 2024-03-12 | |||
| 2020-12-31 | -$2.38M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |